Because those regions influence dopamine signaling , researchers have been investigating whether GLP-1 drugs might also affect behaviors tied to reward and addiction
Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material
We pair microdosing with physician oversight, lab tracking, and ongoing support to improve consistency and comfort
Previous studies have shown that the Taq1A polymorphism is linked to obesity-related outcomes in children, where individuals with polymorphisms that have decreased basal dopaminergic signaling could potentially be at risk for increased psychiatric side effects following GLP-1RA administration [159]
This article examines current evidence on gastroparesis incidence, risk factors, diagnostic approaches, and management strategies for patients using GLP-1 medications
